Arrowhead Research | ARWR - Ebit





Ebit Veränderung Datum
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
Merck USD -1.88B 8.12B 2026-03
Moderna USD -1.39B 531M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.18B 118M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xencor USD -77.86M 24.23M 2026-03